Schistosomiasis – Page 2

December 12, 2021 • Schistosomiasis Infection

Praziquantel Treatment of Schistosoma mansoni Infected Mice Renders Them Less Susceptible to Reinfection.

Nono JK, Mpotje T, Mosala P, Aziz NA, Musaigwa F, Hlaka L, Spangenberg T and Brombacher F. We report here, with experimental proof in a murine tractable model of high transmission, the added benefit that deworming with praziquantel might have for achieving elimination of schistosomiasis by fostering the development of resistance to reinfection in the […]

August 31, 2021 • Schistosomiasis Infection

Negative Association of Interleukin-33 Plasma Levels and Schistosomiasis Infection in a Site of Polyparasitism in Rural Cameroon

We convincingly report on a negative association between plasma IL-33 levels and schistosomiasis infection and egg burden in school children from a polyparasitic schistosomiasis endemic area. A suggested potential of IL-33 as biomarker of schistosomiasis infection is proposed.

August 30, 2021 • Vaccine

Influence of schistosomiasis on host vaccine responses

Here, we review available evidence on the influence of transgenerational and direct Schistosoma parasite exposure on host immune responses to unrelated vaccines. In addition, we evaluate the potential of praziquantel (PZQ) treatment in restoring schistosomiasis-impacted vaccine responses

Latest updates about the lab

Praziquantel Treatment of Schistosoma mansoni Infected Mice Renders Them Less Susceptible to Reinfection.

Negative Association of Interleukin-33 Plasma Levels and Schistosomiasis Infection in a Site of Polyparasitism in Rural Cameroon

Influence of schistosomiasis on host vaccine responses